Pictet Asset Management Holding SA Has $104.66 Million Stock Position in McKesson Corporation $MCK

Key Points

• Pictet Asset Management increased its holding in McKesson by 11.8% in Q4 to 127,575 shares worth $104.66 million, representing about 0.10% of the company.
• McKesson beat Q4 estimates with EPS $9.34 (vs. $9.19 expected) and revenue of $106.16 billion (up 11.4% YoY), and set FY2026 guidance of EPS $38.80–39.20 (analysts forecast ~39.02).
• The company declared a quarterly dividend of $0.82 (annualized $3.28, yield ~0.4%, ex-dividend June 1), and the stock carries a consensus rating of "Moderate Buy" with a target price of $972.27.

Pictet Asset Management Holding SA grew its position in shares of McKesson Corporation (NYSE:MCK - Free Report) by 11.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 127,575 shares of the company's stock after acquiring an additional 13,479 shares during the quarter. Pictet Asset Management Holding SA owned 0.10% of McKesson worth $104,664,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. GGM Financials LLC acquired a new stake in shares of McKesson in the 3rd quarter valued at approximately $25,000. State of Wyoming acquired a new stake in shares of McKesson in the 2nd quarter valued at approximately $29,000. Hopwood Financial Services Inc. acquired a new stake in shares of McKesson in the 3rd quarter valued at approximately $31,000. Vermillion & White Wealth Management Group LLC acquired a new stake in shares of McKesson in the 3rd quarter valued at approximately $33,000. Finally, Board of the Pension Protection Fund acquired a new stake in shares of McKesson in the 4th quarter valued at approximately $33,000. Institutional investors and hedge funds own 85.07% of the company's stock.

McKesson Trading Up 0.0%

MCK opened at $828.16 on Tuesday. McKesson Corporation has a 1-year low of $637.00 and a 1-year high of $999.00. The stock's fifty day simple moving average is $902.00 and its 200 day simple moving average is $859.23. The stock has a market cap of $101.44 billion, a PE ratio of 23.82, a price-to-earnings-growth ratio of 1.19 and a beta of 0.42.

McKesson (NYSE:MCK - Get Free Report) last posted its quarterly earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share for the quarter, beating analysts' consensus estimates of $9.19 by $0.15. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The business had revenue of $106.16 billion for the quarter, compared to analysts' expectations of $105.98 billion. During the same quarter in the prior year, the business earned $8.03 EPS. The firm's revenue for the quarter was up 11.4% on a year-over-year basis. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. Equities analysts forecast that McKesson Corporation will post 39.02 earnings per share for the current year.

McKesson Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 1st. Investors of record on Monday, June 1st will be paid a $0.82 dividend. This represents a $3.28 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date is Monday, June 1st. McKesson's dividend payout ratio is 9.43%.

Analyst Upgrades and Downgrades

MCK has been the subject of several recent analyst reports. Robert W. Baird set a $968.00 price objective on McKesson in a report on Wednesday, January 14th. Bank of America cut their price objective on McKesson from $1,040.00 to $1,000.00 and set a "buy" rating for the company in a report on Monday, April 6th. Leerink Partners reissued an "outperform" rating and issued a $1,085.00 price objective on shares of McKesson in a report on Thursday, March 5th. UBS Group cut their price objective on McKesson from $1,012.00 to $1,000.00 and set a "buy" rating for the company in a report on Wednesday, April 22nd. Finally, Mizuho increased their price objective on McKesson from $880.00 to $885.00 and gave the company a "neutral" rating in a report on Thursday, February 5th. Thirteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $972.27.

Insiders Place Their Bets

In related news, EVP Leann B. Smith sold 190 shares of the stock in a transaction on Tuesday, February 17th. The stock was sold at an average price of $945.00, for a total value of $179,550.00. Following the sale, the executive vice president owned 2,989 shares in the company, valued at approximately $2,824,605. This represents a 5.98% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Michele Lau sold 2,725 shares of the stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $990.00, for a total value of $2,697,750.00. Following the completion of the sale, the executive vice president owned 3,247 shares in the company, valued at approximately $3,214,530. This trade represents a 45.63% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 3,592 shares of company stock worth $3,518,555 in the last quarter. Insiders own 0.08% of the company's stock.

McKesson Profile

McKesson Corporation NYSE: MCK is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company's core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.

Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Corporation (NYSE:MCK - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.